Evidence map›Paper›PMID 38732221›Full record

ReviewInternational journal of molecular sciences2024

The Role of Inflammasome in Abdominal Aortic Aneurysm and Its Potential Drugs.

Suyu Pi, Sizheng Xiong, Yan Yuan, Hongping Deng

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Suyu PiDepartment of Vascular Surgery, Renmin Hospital of Wuhan University, Wuhan 430060, China.
Sizheng XiongDepartment of Vascular Surgery, Renmin Hospital of Wuhan University, Wuhan 430060, China.ORCID 0000-0002-0219-0480
Yan YuanDepartment of Vascular Surgery, Renmin Hospital of Wuhan University, Wuhan 430060, China.
Hongping DengDepartment of Vascular Surgery, Renmin Hospital of Wuhan University, Wuhan 430060, China.ORCID 0009-0008-9626-8410

Funding

the Fundamental Research Funds for the Central Universities No. 2042023kf0040the Scientific Research Innovation Fund Project of Wuhan Wuchang Hospital No. WCYY2022Y03the Special Project of Central Government Guiding Local Science and Technology Development in Hubei Province No. 2020ZYYD002
6 · The paper itself

Abstract

Abdominal aortic aneurysm (AAA) has been recognized as a serious chronic inflammatory degenerative aortic disease in recent years. At present, there is no other effective intervention except surgical treatment for AAA. With the aging of the human population, its incidence is increasing year by year, posing a serious threat to human health. Modern studies suggest that vascular chronic inflammatory response is the core process in AAA occurrence and development. Inflammasome, a multiprotein complex located in the cytoplasm, mediates the expression of various inflammatory cytokines like interleukin (IL)-1β and IL-18, and thus plays a pivotal role in inflammation regulation. Therefore, inflammasome may exert a crucial influence on the progression of AAA. This article reviews some mechanism studies to investigate the role of inflammasome in AAA and then summarizes several potential drugs targeting inflammasome for the treatment of AAA, aiming to provide new ideas for the clinical prevention and treatment of AAA beyond surgical methods.

Indexed as

Aortic Aneurysm, AbdominalInflammasomesAnimalsHumansInflammationInflammasomesabdominal aortic aneurysmactivation and regulationAIM2inflammasomeinflammationNLRP3potential drugs

Identifiers

PMID38732221
PMCPMC11084561

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.